Insider Trading History of Polaris Venture Partners Special Founders' Fund V, L.p.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Polaris Venture Partners Special Founders' Fund V, L.p. since year 2005. The trader's CIK number is 1439586. At the time of the last reporting, Polaris Venture Partners Special Founders' Fund V, L.p. was the 10% Owner of Cardlytics, Inc. . (stock ticker symbol CDLX). See this page for all insider trading activities at Cardlytics, Inc. .

Note that in the past Polaris Venture Partners Special Founders' Fund V, L.P. also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Polaris Venture Partners Special Founders' Fund V, L.p. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-06-07 CDLX Cardlytics, Inc. Sale 100,000 25.62 2,562,100
2019-06-04 CDLX Cardlytics, Inc. Sale 36,378 23.28 846,952
2019-06-05 CDLX Cardlytics, Inc. Sale 38,601 24.64 951,244
2019-06-06 CDLX Cardlytics, Inc. Sale 305 25.00 7,625
2019-05-28 CDLX Cardlytics, Inc. Sale 100,000 23.04 2,303,800
2018-09-13 CDLX Cardlytics, Inc. Sale 50,000 25.96 1,298,250
2018-09-12 CDLX Cardlytics, Inc. Sale 100,000 24.93 2,492,900
2018-08-09 CDLX Cardlytics, Inc. Option Ex 66,364 .00 0
2018-04-03 PULM Pulmatrix, Inc. Buy 1,150,000 .00 0
2016-06-27 SELB Selecta Biosciences Inc Buy 150,000 14.00 2,100,000
2015-06-18 GNCA Genocea Biosciences, Inc. Sale 29,004 13.04 378,212
2015-06-19 GNCA Genocea Biosciences, Inc. Sale 1,000 13.00 13,000
2015-06-15 PULM Pulmatrix, Inc. Buy 106,693 6.88 733,514
2015-06-16 GNCA Genocea Biosciences, Inc. Sale 46,000 13.24 609,040
2015-06-17 GNCA Genocea Biosciences, Inc. Sale 10,618 13.01 138,140
2015-02-02 OCUL Ocular Therapeutix, Inc Sale 500,000 29.50 14,750,000
2014-08-14 GNCA Genocea Biosciences, Inc. Sale 6,755 13.01 87,882
2014-08-13 GNCA Genocea Biosciences, Inc. Sale 2,905 13.00 37,765
2014-08-08 GNCA Genocea Biosciences, Inc. Sale 41,376 13.41 554,852
2014-08-11 GNCA Genocea Biosciences, Inc. Sale 1,428 13.24 18,906
2014-08-12 GNCA Genocea Biosciences, Inc. Sale 20,990 13.03 273,499
2014-04-15 CERU Dare Bioscience, Inc. Buy 1,470,582 7.00 10,294,074
2013-10-04 FATE Fate Therapeutics Inc Buy 833,333 6.00 4,999,998

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Polaris Venture Partners Special Founders' Fund V, L.p. (10% Owner of Cardlytics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.